Kehoe PG - Search Results

1

A Validation Study of Vascular Cognitive Impairment Genetics Meta-Analysis Findings in an Independent Collaborative Cohort.

Skrobot OA, McKnight AJ, Passmore PA, Seripa D, Mecocci P, Panza F, Kalaria R, Wilcock G, Munafò M, Erkinjuntti T, Karhunen P, Pessi T, Martiskainen M, Love S; Genetic and Environmental Risk for Alzheimer’s disease Consortium (GERAD1); Kehoe PG. Skrobot OA, et al. Among authors: kehoe pg. J Alzheimers Dis. 2016 Jun 15;53(3):981-9. doi: 10.3233/JAD-150862. J Alzheimers Dis. 2016. PMID: 27314523

2

Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy.

Miners JS, Van Helmond Z, Chalmers K, Wilcock G, Love S, Kehoe PG. Miners JS, et al. Among authors: kehoe pg. J Neuropathol Exp Neurol. 2006 Oct;65(10):1012-21. doi: 10.1097/01.jnen.0000240463.87886.9a. J Neuropathol Exp Neurol. 2006. PMID: 17021406

3

Immunocapture-based fluorometric assay for the measurement of neprilysin-specific enzyme activity in brain tissue homogenates and cerebrospinal fluid.

Miners JS, Verbeek MM, Rikkert MO, Kehoe PG, Love S. Miners JS, et al. Among authors: kehoe pg. J Neurosci Methods. 2008 Jan 30;167(2):229-36. doi: 10.1016/j.jneumeth.2007.08.012. Epub 2007 Aug 25. J Neurosci Methods. 2008. PMID: 17904641

4

Immunocapture-based fluorometric assay for the measurement of insulin-degrading enzyme activity in brain tissue homogenates.

Miners JS, Kehoe PG, Love S. Miners JS, et al. Among authors: kehoe pg. J Neurosci Methods. 2008 Mar 30;169(1):177-81. doi: 10.1016/j.jneumeth.2007.12.003. Epub 2007 Dec 17. J Neurosci Methods. 2008. PMID: 18221786

5

Insights into the pathogenesis and pathogenicity of cerebral amyloid angiopathy.

Love S, Miners S, Palmer J, Chalmers K, Kehoe P. Love S, et al. Front Biosci (Landmark Ed). 2009 Jan 1;14(12):4778-92. doi: 10.2741/3567. Front Biosci (Landmark Ed). 2009. PMID: 19273389 Free article. Review.

6

Neprilysin and insulin-degrading enzyme levels are increased in Alzheimer disease in relation to disease severity.

Miners JS, Baig S, Tayler H, Kehoe PG, Love S. Miners JS, et al. Among authors: kehoe pg. J Neuropathol Exp Neurol. 2009 Aug;68(8):902-14. doi: 10.1097/NEN.0b013e3181afe475. J Neuropathol Exp Neurol. 2009. PMID: 19606063

7

Accumulation of insoluble amyloid-β in down's syndrome is associated with increased BACE-1 and neprilysin activities.

Miners JS, Morris S, Love S, Kehoe PG. Miners JS, et al. Among authors: kehoe pg. J Alzheimers Dis. 2011;23(1):101-8. doi: 10.3233/JAD-2010-101395. J Alzheimers Dis. 2011. PMID: 20930275

8

Neprilysin protects against cerebral amyloid angiopathy and Aβ-induced degeneration of cerebrovascular smooth muscle cells.

Miners JS, Kehoe P, Love S. Miners JS, et al. Brain Pathol. 2011 Sep;21(5):594-605. doi: 10.1111/j.1750-3639.2011.00486.x. Epub 2011 Apr 3. Brain Pathol. 2011. PMID: 21382117 Free PMC article.

9

Aβ-degrading enzymes: potential for treatment of Alzheimer disease.

Miners JS, Barua N, Kehoe PG, Gill S, Love S. Miners JS, et al. Among authors: kehoe pg. J Neuropathol Exp Neurol. 2011 Nov;70(11):944-59. doi: 10.1097/NEN.0b013e3182345e46. J Neuropathol Exp Neurol. 2011. PMID: 22002425 Review.

10

Associations of angiotensin targeting antihypertensive drugs with mortality and hospitalization in primary care patients with dementia.

Kehoe PG, Davies NM, Martin RM, Ben-Shlomo Y. Kehoe PG, et al. J Alzheimers Dis. 2013;33(4):999-1008. doi: 10.3233/JAD-2012-121090. J Alzheimers Dis. 2013. PMID: 23076074

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

211 results

Search Page